Bill > HB1034

This bill addresses the treatment of nonopioid pain medications by health plans, state employee health benefits, and Medicaid programs, requiring equal or more favorable coverage for nonopioid drugs compared to opioid medications. Specifically, the bill prohibits health plans issued or renewed after January 1, 2026, from implementing drug practices that discourage nonopioid pain treatments, such as designating nonopioid drugs as non-preferred when opioids are preferred or creating more restrictive prior authorization or step therapy requirements for nonopioid drugs. The bill defines a "nonopioid drug" as a medication approved by the FDA that provides pain relief without acting on opioid receptors. Additionally, the Washington State Department of Health is required to develop and publish an educational pamphlet by January 1, 2026, providing information about nonopioid pain treatment alternatives, including both medicinal and non-pharmacological options, and detailing their advantages and disadvantages. This legislation aims to provide patients and healthcare providers with more flexible and potentially safer pain management options by reducing barriers to nonopioid treatments.

Health and Social Services

https://app.leg.wa.gov/billsummary?BillNumber=1034&Year=2025&Initiative=false